Your browser doesn't support javascript.
loading
Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma.
Fattore, Luigi; Ruggiero, Ciro Francesco; Pisanu, Maria Elena; Liguoro, Domenico; Cerri, Andrea; Costantini, Susan; Capone, Francesca; Acunzo, Mario; Romano, Giulia; Nigita, Giovanni; Mallardo, Domenico; Ragone, Concetta; Carriero, Maria Vincenza; Budillon, Alfredo; Botti, Gerardo; Ascierto, Paolo Antonio; Mancini, Rita; Ciliberto, Gennaro.
Afiliación
  • Fattore L; IRCCS, Regina Elena National Cancer Institute, Rome, Italy.
  • Ruggiero CF; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Catanzaro, Italy.
  • Pisanu ME; Department of Molecular and Clinical Medicine, University of Roma "Sapienza", Rome, Italy.
  • Liguoro D; Department of Molecular and Clinical Medicine, University of Roma "Sapienza", Rome, Italy.
  • Cerri A; IRCCS, Regina Elena National Cancer Institute, Rome, Italy.
  • Costantini S; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Capone F; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Acunzo M; Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  • Romano G; Division of Pulmonary Disease and Critical Care Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  • Nigita G; Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Mallardo D; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Ragone C; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Carriero MV; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Budillon A; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Botti G; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Ascierto PA; IRCCS, National Cancer Institute of Naples "Fondazione G. Pascale", Naples, Italy.
  • Mancini R; Department of Molecular and Clinical Medicine, University of Roma "Sapienza", Rome, Italy.
  • Ciliberto G; IRCCS, Regina Elena National Cancer Institute, Rome, Italy. gennaro.ciliberto@ifo.gov.it.
Cell Death Differ ; 26(7): 1267-1282, 2019 07.
Article en En | MEDLINE | ID: mdl-30254376
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_antimicrobial_resistance / 6_malignant_skin_melanoma Asunto principal: Resistencia a Antineoplásicos / MicroARNs / Inhibidores de Proteínas Quinasas / Vemurafenib / Melanoma / Mutación / Antineoplásicos Límite: Humans Idioma: En Revista: Cell Death Differ Año: 2019 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_antimicrobial_resistance / 6_malignant_skin_melanoma Asunto principal: Resistencia a Antineoplásicos / MicroARNs / Inhibidores de Proteínas Quinasas / Vemurafenib / Melanoma / Mutación / Antineoplásicos Límite: Humans Idioma: En Revista: Cell Death Differ Año: 2019 Tipo del documento: Article País de afiliación: Italia